196 related articles for article (PubMed ID: 6740546)
1. Platelet-platelet recognition during aggregation: distinct mechanisms determined by the release reaction.
Agam G; Livne A
Thromb Haemost; 1984 Apr; 51(2):145-9. PubMed ID: 6740546
[TBL] [Abstract][Full Text] [Related]
2. Resolution and reconstitution of interplatelet recognition during aggregation.
Agam G; Livne A
Thromb Haemost; 1988 Jun; 59(3):504-6. PubMed ID: 3187935
[TBL] [Abstract][Full Text] [Related]
3. Effect of amino sugars on platelet aggregation and on fibrinogen binding.
Kinlough-Rathbone RL; Packham MA; Mustard JF
Thromb Haemost; 1984 Aug; 52(1):75-80. PubMed ID: 6495268
[TBL] [Abstract][Full Text] [Related]
4. Thrombospondin plays a role in platelet-platelet recognition during release-related aggregation.
Agam G; Shohat O; Livne A
Proc Soc Exp Biol Med; 1984 Dec; 177(3):482-6. PubMed ID: 6514723
[TBL] [Abstract][Full Text] [Related]
5. Regulation of platelet aggregation by post-fibrinogen binding events. Insights provided by dithiothreitol-treated platelets.
Peerschke EI
Thromb Haemost; 1995 May; 73(5):862-7. PubMed ID: 7482417
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen fragment D is a recognition site for release-related platelet aggregation.
Agam G; Shohat O; Livne A
Thromb Res; 1985 Mar; 37(6):629-38. PubMed ID: 3992532
[TBL] [Abstract][Full Text] [Related]
8. Binding of aggregated immunoglobulins to the human platelet Fc receptors: a mechanism of platelet to platelet bridging.
Parbtani A; Clark WF; Caveney A; Reid B
Thromb Haemost; 1987 Dec; 58(4):966-70. PubMed ID: 3127922
[TBL] [Abstract][Full Text] [Related]
9. Relationship of ADP-induced fibrinogen binding to platelet shape change and aggregation elucidated by use of colchicine and cytochalasin B.
Peerschke EI; Zucker MB
Thromb Haemost; 1980 Feb; 43(1):58-60. PubMed ID: 7404479
[TBL] [Abstract][Full Text] [Related]
10. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression.
Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL
Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947
[TBL] [Abstract][Full Text] [Related]
11. Association of fibrinogen with human platelets pretreated with chymotrypsin or aggregated with ADP or thrombin: an immunocytochemical study.
Suzuki H; Kinlough-Rathbone RL; Packham MA; Yamazaki H; Mustard JF
Br J Exp Pathol; 1989 Aug; 70(4):479-88. PubMed ID: 2765399
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin enhances platelet aggregation induced by adenosine diphosphate in vitro.
Wu Q; Huang KS; Chen M; Huang DJ
Platelets; 2009 Sep; 20(6):428-31. PubMed ID: 19639515
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen.
Harfenist EJ; Packham MA; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1981 May; 97(5):680-8. PubMed ID: 6783712
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing the deaggregation of human and rabbit platelets.
Kinlough-Rathbone RL; Mustard JF; Perry DW; Dejana E; Cazenave JP; Packham MA; Harfenist EJ
Thromb Haemost; 1983 Jun; 49(3):162-7. PubMed ID: 6308846
[TBL] [Abstract][Full Text] [Related]
15. Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling.
Marwali MR; Hu CP; Mohandas B; Dandapat A; Deonikar P; Chen J; Cawich I; Sawamura T; Kavdia M; Mehta JL
J Pharmacol Exp Ther; 2007 Sep; 322(3):1324-32. PubMed ID: 17538005
[TBL] [Abstract][Full Text] [Related]
16. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
[TBL] [Abstract][Full Text] [Related]
17. Effect of epinephrine on fibrinogen receptor exposure by aspirin-treated platelets and platelets from concentrates in response to ADP and thrombin.
Peerschke EI
Am J Hematol; 1984 May; 16(4):335-45. PubMed ID: 6326566
[TBL] [Abstract][Full Text] [Related]
18. Passive participation of fixed platelets in aggregation facilitated by covalently bound fibrinogen.
Agam G; Livne A
Blood; 1983 Jan; 61(1):186-91. PubMed ID: 6848143
[TBL] [Abstract][Full Text] [Related]
19. Effects of tris on responses of human and rabbit platelets to aggregating agents.
Packham MA; Guccione MA; Nina M; Kinlough-Rathbone RL; Mustard JF
Thromb Haemost; 1984 Apr; 51(2):140-4. PubMed ID: 6429880
[TBL] [Abstract][Full Text] [Related]
20. Lack of stability of aggregates after thrombin-induced reaggregation of thrombin-degranulated platelets.
Kinlough-Rathbone RL; Packham MA; Perry DW; Mustard JF; Cattaneo M
Thromb Haemost; 1992 Apr; 67(4):453-7. PubMed ID: 1631794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
